Abstract
Review of 496 cases of chronic lymphocytic and chronic lymphosarcoma cell leukemia disclosed a number of minor differences in clinical and laboratory manifestations, but with few exceptions they lacked statistical significance. However, highly significant differences were found in survivorship. It is concluded from these data that morphologic distinction between these two types of chronic lymphocytic leukemia is justified on the basis of the significantly shorter course in the lymphoproliferative disorder which we prefer to designate “chronic lymphosarcoma cell leukemia.” Other pertinent differences do not apppear to exist.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
